Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
-NHF and Community News
 Industry News
 Travel Advisory

 

 

 
MASAC Issues Four New Documents
 

The National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council (MASAC) issued the following documents, which were adopted by NHF’s Board of Directors on June 22, 2012:

 

MASAC Document #211: MASAC Recommendations Regarding Inhibitor Risk and Recombinant Factor VIII Concentrates
 
MASAC Document #210: MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders (Revised May 2012)
 
MASAC Document #209: MASAC Statement on Biosimilars
 
MASAC Document #208: MASAC Recommendation on Orphan Drugs

 

To view these documents, click the links above or review the complete list of current MASAC documents. To request a hard copy of any current documents, please contact HANDI, NHF’s information resource center: handi@hemophilia.org or 1.800.424.2634.

 

This section of our Web site is sponsored by: